Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any precursor B-cell acute lymphoblastic leukemia in which the cause of the disease is a mutation in the PAX5 gene.
Biomarker and diagnostic research for leukemia, acute lymphoblastic, susceptibility to, 3 has been reported in the published literature.
No clinical trials have been registered for leukemia, acute lymphoblastic, susceptibility to, 3.
76 publications have been identified in PubMed for leukemia, acute lymphoblastic, susceptibility to, 3. Research spans Basic Science / Preclinical (29%), Epidemiology / Natural History (28%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 22 | 29% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:12 PM UTC
Online Mendelian Inheritance in Man
Disease patterns and progression |
21 |
28% |
Research summaries | 10 | 13% |
Patient case studies | 9 | 12% |
Testing and diagnosis research | 8 | 11% |
Clinical study results | 4 | 5% |
New treatment approaches | 2 | 3% |
Veneziano-Broccia M (2026). [PMID: 41486745](https://pubmed.ncbi.nlm.nih.gov/41486745/). *Pediatr Blood Cancer*. [Epidemiology / Natural History]
Krishna Leons G (2026). [PMID: 41667079](https://pubmed.ncbi.nlm.nih.gov/41667079/). *Int J Lab Hematol*. [Epidemiology / Natural History]
Liu X (2026). [PMID: 41484610](https://pubmed.ncbi.nlm.nih.gov/41484610/). *Cancer Cell Int*. [Basic Science / Preclinical]
Meng X (2026). [PMID: 42089785](https://pubmed.ncbi.nlm.nih.gov/42089785/). *Cancer Epidemiol Biomarkers Prev*. [Epidemiology / Natural History]
Pootrakul T (2026). [PMID: 41588847](https://pubmed.ncbi.nlm.nih.gov/41588847/). *Clin Chem Lab Med*. [Diagnostic / Biomarker]
Cao X (2026). [PMID: 41923653](https://pubmed.ncbi.nlm.nih.gov/41923653/). *Per Med*. [Basic Science / Preclinical]
Ruiz-Corzo B (2026). [PMID: 41701537](https://pubmed.ncbi.nlm.nih.gov/41701537/). *JCI Insight*. [Basic Science / Preclinical]
Mohd Dali NS (2026). [PMID: 41772825](https://pubmed.ncbi.nlm.nih.gov/41772825/). *Mol Genet Genomic Med*. [Basic Science / Preclinical]
Sabbagh C (2026). [PMID: 41618027](https://pubmed.ncbi.nlm.nih.gov/41618027/). *Eur J Haematol*. [Epidemiology / Natural History]
Mason EJ (2026). [PMID: 41699110](https://pubmed.ncbi.nlm.nih.gov/41699110/). *Support Care Cancer*. [Epidemiology / Natural History]